Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,335
Closed -$307K 210
2020
Q4
$307K Buy
1,335
+804
+151% +$185K 0.19% 122
2020
Q3
$135K Buy
+531
New +$132K 0.1% 154
2019
Q3
Sell
-4,869
Closed -$897K 136
2019
Q2
$897K Sell
4,869
-4,204
-46% -$753K 0.43% 72
2019
Q1
$1.72M Sell
9,073
-6,702
-42% -$1.28M 0.67% 47
2018
Q4
$3.07M Buy
15,775
+1,042
+7% +$203K 1.43% 16
2018
Q3
$3.05M Buy
14,733
+630
+4% +$124K 1.19% 25
2018
Q2
$2.6M Sell
14,103
-3,050
-18% -$540K 0.99% 32
2018
Q1
$2.88M Buy
+17,153
New +$3.15M 1.54% 22

Other funds holding AMGN

Grace Capital's AMGN Position: Q1 2021 in Review

Grace Capital sold out of Amgen (AMGN) in Q1 2021, closing a stake of 1,335 shares — an estimated $307K sold.

Grace Capital first reported a position in AMGN in Q1 2018 and held it in 8 quarters. The position peaked at $3.07M in Q4 2018. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.

  • Grace Capital reported no remaining Amgen position as of Q1 2021 after selling out during the quarter.
  • Grace Capital sold 1,335 Amgen shares in Q1 2021, an estimated $307K.
  • Grace Capital first reported a position in Amgen in Q1 2018 and held it in 8 quarters.
  • Grace Capital's Amgen position peaked at $3.07M in Q4 2018.
  • 2,218 funds tracked by Wall St. Rank held Amgen as of Q1 2021.

Based on Grace Capital's 13F filing for Q1 2021, filed 6 May 2021.